Sources of estrogen and their importance

Journal of Steroid Biochemistry and Molecular Biology

Volumn 86, Issue 3-5, 2003, Pages 225-230

  Simpson, E R ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Aromatase; CYP19; Estrogen

Indexed keywords

AROMATASE; CYCLIC AMP; CYTOCHROME P450; ESTROGEN; GLUCOCORTICOID; PROSTAGLANDIN E2; RETINOID; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BONE MINERALIZATION; BRAIN TISSUE; BREAST; BREAST TUMOR; CARCINOGENESIS; CARTILAGE CELL; COGNITION; CONFERENCE PAPER; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; MACROPHAGE; MESENCHYME CELL; OSTEOBLAST; OVARY; POSTMENOPAUSE; PREMENOPAUSE; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0242457714     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00360-1     Document Type: Conference Paper

References (40)

1. Simpson E.R., Clyne C., Robertson K., O'Donnell L., Jones M., Davis S. The role of local estrogen biosynthesis in males and females. Trends Endocrinol. Metab. 11:2000;184-188.
2. Simpson E.R., Davis S.R. Minireview: aromatase and the regulation of estrogen biosynthesis - some new perspectives. Endocrinology. 142:2001;4589-4594.
3. Simpson E.R., Clyne C., Rubin G., Boon W.-C., Robertson K., Britt K., Speed C., Jones M. Aromatase - a brief overview. Annu. Rev. Physiol. 64:2002;93-127.
4. Labrie F., Belanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogen but of their metabolites' intracrinology. J. Clin. Endocrinol. Metab. 82:1997;2403-2409.
5. F. Labrie, A. Belanger, V. Luu-The, C. Labrie, J. Simond, L. Cusan, J.L. Gomez, B. Candas, DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging, Steroids (1998) 322-328.
6. Wilson J.D., Aiman J., MacDonald P.C. The pathogenesis of gynecomastia. Adv. Intern. Med. 25:1980;1-32.
7. S. Sebastian, M. Shozu, W. Hsu, J. Sarkey, R. Schultz, K. Neely, et al., Estrogen excess caused by gain-of-function mutations of the cyp19 (aromatase) gene involving the chromosome 15q 21.2-q21.3 region, in: Proceedings of the 83rd Annual Meeting of the Endocrine Society, vol. 127, Denver, CO, 2001 (Abstract).
8. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde I., Talbi M.et al. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 81:1996;1460-1464.
9. DeJong P.C., ven de Ven J., Nortier H.W., Maitimu-Sneede I., Danker T.H., Thijssen J.H.et al. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor varozole. Cancer Res. 57:1997;2109-2111.
10. Sasano H., Uzuki M., Sawai T., Nagura H., Matsunaga G., Kashimoto O.et al. Aromatase in bone tissue. J. Bone Miner. Res. 12:1997;1416-1423.
11. Shozu M., Simpson E.R. Aromatase expression of human osteoblast-like cells. Mol. Cell. Endocrinol. 139:1998;117-129.
12. 19 sex steroid precursor. J. Clin. Endocrinol. Metab. 82:1997;2396-2402.
13. Simpson E.R., Rubin G., Clyne C., Robertson K., O'Donnell L., Jones M., Davis S. The role of local estrogen biosynthesis in males and females. Trends Endocrinol. Metab. 11:2000;184-188.
14. Morishima A., Grumbach M.M., Simipson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80:1995;3689-3698.
15. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J. et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337:1997;91-95.
16. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B.et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331:1994;1056-1061.
17. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11162-11166.
18. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F.et al. Generation and reproductive phenotypes of mice lacking estrogen receptor-β Proc. Natl. Acad. Sci. U.S.A. 95:1998;15677-15682.
19. Couse J.F., Hewitt S.C., Bunch D.O., Sar M., Walker V.R., Davis B.J.et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β Science. 286:1999;2328-2331.
20. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., Mark M. Effect of single and compound knockouts of estrogen receptor alpha (ERα) and beta (ERβ) on mouse reproductive phenotypes. Development. 127:2000;4277-4291.
21. Fisher C.R., Graves K.H., Parlow A.F., Simpson E.R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6965-6970.
22. Honda S., Harada N., Takagi Y., Maeda S. Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene. Biochem. Biophys. Res. Commun. 252:1998;445-449.
23. Nemoto Y., Toda K., Ono M., Fujikawa-Adachi K., Saibara T., Onishi S.et al. Altered expression of fatty acid metabolising enzymes in aromatase-deficient mice. J. Clin. Invest. 105:2000;1819-1825.
24. Jones M.E.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J.et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U.S.A. 97:2000;12735-12740.
25. Oz O.K., Zerwekh J.E., Fisher C., Graves K., Nanu L., Millsaps R.et al. Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner. Res. 15:2000;507-514.
26. Robertson K., O'Donnell L., Jones M.E.E., Meachem S.J., Boon W.C., Fisher C.R.et al. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp19) gene. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7986-7991.
27. Eddy E.M., Washburn T.F., Bunch D.O., Goulding E.H., Gladen B.C., Lubahn D.B.et al. Targeted disruption of the oestrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology. 137:1996;4796-4805.
28. Nakai M., Bouma J., Nie R., Zhou Q., Carnes K., Lubahn D.B.et al. Morphological analysis of endocytosis in efferent ductules of estrogen receptor-alpha knockout male mouse. Anat. Rec. 263:2001;10-18.
29. Callard G.V., Petro Z., Ryan K.J. Phylogenetic distribution of aromatase and other androgen-converting enzymes of the central nervous system. Endocrinology. 103:1978;2283-2290.
30. Kishida M., Callard G.V. Distinct cytochrome P450 aromatase isoforms in zebrafish (D. rerio) brain and ovary are differentially regulated during early development. Endocrinology. 142:2001;740-750.
31. J.W. Thornton, Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions, Proc. Natl. Acad. Sci. U.S.A. (2001) 5671-5676.
32. Simpson E.R., Zhao Y., Agarwal V.R., Michael M.D., Bulun S.E., Hinshelwood M.M., Graham-Lorence S., Tun T., Fisher C.R., Qin K., Mendelson C.R. Aromatase expression in health and disease. Recent Prog. Horm. Res. 52:1997;185-214.
33. Agarwal V.R., Bulun S.E., Simpson E.R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in neoplastic and non-neoplastic adipose tissues of breast cancer patients. J. Clin. Endocrinol. Metab. 81:1996;3843-3849.
34. Zhao Y., Agarwal V.R., Mendelson C.R., Simpson E.R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cAMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology. 137:1996;5739-5742.
35. Harada N., Utsume T., Takagi Y. Tissue-specific expression of the human aromatase cytochrome P450 gene by alternative use of multiple exons I and promoters, and switching of tissue-specific exons I in carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11312-11316.
36. Simpson E.R., Dowsett M. Aromatase and its inhibitors - significance for breast cancer therapy. Recent Prog. Horm. Res. 57:2002;317-338.
37. Bonneterre J., Thurlimann B., Robertson J.F., Krzakowski M., Mauriac L., Koralewski P., Vergote I., Webster A., Steinberg M., von Euler M. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study. J. Clin. Oncol. 18:2000;3748-3757.
38. Mouridsen H., Gershanovich M., Sun Y., Perez-Carrion R., Boni C., Monnier A., Apffelstaedt J., Smith R., Sleeboom H.P., Janicke F., Pluzanska A., Dank M., Becquart D., Bapsy P.P., Salminen E., Snyder R., Lassus M., Verbeek J.A., Staffler B., Chaudri-Ross H.A., Dugan M. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women: results of a phase III study of the International Letrozole Breast Cancer Group. J. Clin. Oncol. 18:2000;3758-3767.
39. Nabholtz J.M., Buzdar A., Pollak M., Harwin W., Burton G., Mangalik A., Steinberg M., Webster A., von Euler M. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomised trial. Arimidex Study Group. J. Clin. Oncol. 18:2000;3758-3767.
40. M. Watanabe, E.R. Simipson, C.D. Clyne, P450 aromatase expression in human osteoblast-like (SV-HFO) cells, Mol. Endocrinol., in press.